Observational study on clinical outcome prediction of anti-epidermal growth factor receptor for colorectal cancer based on DNA methylation status and gene expression status.

ABSTRACT: Primary outcome(s): PFS (Progression Free Survival) / RR (Response Rate)

DISEASE(S): Metastatic Colorectal Cancer

PROVIDER: 2642510 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR